| Literature DB >> 23866020 |
Douglas A Hansen1, Christopher M Rath, Eli B Eisman, Alison R H Narayan, Jeffrey D Kittendorf, Jonathan D Mortison, Yeo Joon Yoon, David H Sherman.
Abstract
A biocatalytic platform that employs the final two monomodular type I polyketide synthases of the pikromycin pathway in vitro followed by direct appendage of D-desosamine and final C-H oxidation(s) in vivo was developed and applied toward the synthesis of a suite of 12- and 14-membered ring macrolide natural products. This methodology delivered both compound classes in 13 steps (longest linear sequence) from commercially available (R)-Roche ester in >10% overall yields.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23866020 PMCID: PMC3771335 DOI: 10.1021/ja404134f
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419